Skip to content
AwardedCzechiaGoodsCZK 58,890,624

Pluvicto III 2024

Published
Published 6 December 2024
Deadline
Closed 16 May 2025

Overview

Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků splňujících požadavky SÚKL s obsahem účinné látky LUTECIUM-(177LU) VIPIVOTID TETRAXETAN

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 58,890,624
Procedure
Open
SME suitable
Yes
Published
6 December 2024
Deadline
Closed
Classification (CPV)
Radioactive materialsVarious medicinal products

Award outcome

Awarded value
CZK 59,345,304
Award date
21 August 2025
Contract period
1 April 2025 → 22 March 2027
Winner
  • Novartis s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 September 2025

  2. Contract Notice

    2 May 2025

  3. Contract Notice

    28 April 2025

  4. Contract Notice

    7 April 2025

  5. Contract Notice

    10 March 2025

  6. Contract Notice

    14 February 2025

  7. Contract Notice

    13 January 2025

  8. Contract Notice

    10 January 2025

  9. Contract Notice

    6 December 2024

Contracting authority

  • Fakultní nemocnice Olomouc

    Procuring entity

    Olomouc - Nová Ulice, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Pluvicto III 2024 — won by Novartis s.r.o. — Skim